Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoîte Mery

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
La Revue Du Praticien|December 5, 2018
Benoîte Mery, Guillaume Moriceau, Romain Rivoirard, et al.
Swiss Medical Weekly|April 5, 2019
High-throughput sequencing in clinical oncology: from past to presentBenoîte Mery, Alexis Vallard, Elise Rowinski, et al.
La Revue Du Praticien|December 5, 2018
Benoîte Mery, Guillaume Moriceau, Romain Rivoirard, et al.
International Journal of Molecular Sciences|December 24, 2021
Targeting AKT in ER-Positive HER2-Negative Metastatic Breast Cancer: From Molecular Promises to Real Life Pitfalls?Benoîte Mery, Coralie Poulard, Muriel Le Romancer, et al.
Bulletin Du Cancer|January 1, 2019
Benoîte Mery, Antoine Thiery-Vuillemin, Christophe Massard, et al.
Bulletin Du Cancer|January 1, 2019
Benoîte Mery, Samuel Jones, Alexis Vallard, et al.
American Journal of Clinical Oncology|July 18, 2019
Maintenance Therapy in Metastatic Solid Tumors: Innovative Strategy or Simple Second-line Treatment?Elise Rowinski, Pierre Fournel, Emilie Bernichon, et al.
Bulletin Du Cancer|January 1, 2019
Benoîte Mery, Chloé Rancoule, Elise Rowinski, et al.
Oncology|April 3, 2019
Advocacy for a New Oncology Research Paradigm: The Model of Bevacizumab in Triple-Negative Breast Cancer in a French Cohort StudyBenoîte Mery, Elise Rowinski, Alexis Vallard, et al.
Bulletin Du Cancer|June 19, 2021
[New therapeutic strategies in HER2-positive breast cancer]Benoîte Mery, Philippe Toussaint, Pierre-Etienne Heudel, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|December 5, 2018
Benoîte Mery, Guillaume Moriceau, Romain Rivoirard, et al.
Swiss Medical Weekly|April 5, 2019
High-throughput sequencing in clinical oncology: from past to presentBenoîte Mery, Alexis Vallard, Elise Rowinski, et al.
La Revue Du Praticien|December 5, 2018
Benoîte Mery, Guillaume Moriceau, Romain Rivoirard, et al.
International Journal of Molecular Sciences|December 24, 2021
Targeting AKT in ER-Positive HER2-Negative Metastatic Breast Cancer: From Molecular Promises to Real Life Pitfalls?Benoîte Mery, Coralie Poulard, Muriel Le Romancer, et al.
Bulletin Du Cancer|January 1, 2019
Benoîte Mery, Antoine Thiery-Vuillemin, Christophe Massard, et al.
Bulletin Du Cancer|January 1, 2019
Benoîte Mery, Samuel Jones, Alexis Vallard, et al.
American Journal of Clinical Oncology|July 18, 2019
Maintenance Therapy in Metastatic Solid Tumors: Innovative Strategy or Simple Second-line Treatment?Elise Rowinski, Pierre Fournel, Emilie Bernichon, et al.
Bulletin Du Cancer|January 1, 2019
Benoîte Mery, Chloé Rancoule, Elise Rowinski, et al.
Oncology|April 3, 2019
Advocacy for a New Oncology Research Paradigm: The Model of Bevacizumab in Triple-Negative Breast Cancer in a French Cohort StudyBenoîte Mery, Elise Rowinski, Alexis Vallard, et al.
Bulletin Du Cancer|June 19, 2021
[New therapeutic strategies in HER2-positive breast cancer]Benoîte Mery, Philippe Toussaint, Pierre-Etienne Heudel, et al.
Pageof 2